---
title: "TD Waterhouse Canada Inc. Sells 4,173 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)"
description: "TD Waterhouse Canada Inc. significantly reduced its stake in TransMedics Group, Inc. (NASDAQ:TMDX) by selling 4,173 shares, resulting in a 90.8% decrease in holdings during the fourth quarter. The fir"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/238417483.md"
published_at: "2025-05-01T08:35:14.000Z"
---

# TD Waterhouse Canada Inc. Sells 4,173 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)

> TD Waterhouse Canada Inc. significantly reduced its stake in TransMedics Group, Inc. (NASDAQ:TMDX) by selling 4,173 shares, resulting in a 90.8% decrease in holdings during the fourth quarter. The firm now owns 425 shares valued at $26,000. Other institutional investors, including Vanguard Group and FIL Ltd, have also adjusted their positions in TMDX. The stock currently has a market cap of $3.05 billion and an average rating of "Moderate Buy" with a consensus price target of $122.70.

TD Waterhouse Canada Inc. trimmed its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 90.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 425 shares of the company's stock after selling 4,173 shares during the quarter. TD Waterhouse Canada Inc.'s holdings in TransMedics Group were worth $26,000 at the end of the most recent reporting period.

Get **TransMedics Group** alerts:

-   3 Stocks Well Below 52-Week Highs With Strong Growth Projections

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of TransMedics Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 3,635,919 shares of the company's stock worth $226,700,000 after acquiring an additional 40,860 shares during the period. FIL Ltd raised its holdings in shares of TransMedics Group by 28.0% during the fourth quarter. FIL Ltd now owns 1,000,358 shares of the company's stock worth $62,372,000 after acquiring an additional 218,961 shares during the period. Geode Capital Management LLC raised its holdings in shares of TransMedics Group by 1.2% during the fourth quarter. Geode Capital Management LLC now owns 772,744 shares of the company's stock worth $48,191,000 after acquiring an additional 8,954 shares during the period. Wasatch Advisors LP raised its holdings in shares of TransMedics Group by 83.3% during the fourth quarter. Wasatch Advisors LP now owns 441,354 shares of the company's stock worth $27,518,000 after acquiring an additional 200,603 shares during the period. Finally, Emerald Advisers LLC raised its holdings in shares of TransMedics Group by 146.3% during the fourth quarter. Emerald Advisers LLC now owns 371,711 shares of the company's stock worth $23,176,000 after acquiring an additional 220,804 shares during the period. 99.67% of the stock is owned by institutional investors.

## Analyst Upgrades and Downgrades

TMDX has been the topic of a number of research analyst reports. Needham & Company LLC restated a "hold" rating on shares of TransMedics Group in a report on Wednesday, April 23rd. Canaccord Genuity Group reiterated a "buy" rating and issued a $104.00 price target on shares of TransMedics Group in a research note on Tuesday, March 11th. Three analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $122.70.

**Get Our Latest Analysis on TransMedics Group**

## TransMedics Group Stock Performance

Shares of NASDAQ TMDX opened at $90.19 on Tuesday. The stock has a 50 day moving average price of $74.67 and a 200 day moving average price of $77.10. TransMedics Group, Inc. has a 52 week low of $55.00 and a 52 week high of $177.37. The company has a debt-to-equity ratio of 2.42, a quick ratio of 7.33 and a current ratio of 8.20. The stock has a market capitalization of $3.05 billion, a PE ratio of 95.95 and a beta of 2.14.

## About TransMedics Group

(Free Report)

TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.

## Featured Articles

-   Five stocks we like better than TransMedics Group
-   What Is WallStreetBets and What Stocks Are They Targeting?
-   Best Defense Stocks in 2025... So Far
-   How to Short Nasdaq: An Easy-to-Follow Guide
-   Alphabet Rebounds After Strong Earnings and Buyback Announcement
-   A Deeper Look at Bid-Ask Spreads
-   Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?

**Want to see what other hedge funds are holding TMDX?** Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TransMedics Group, Inc. (NASDAQ:TMDX - Free Report).

*This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.*

## Should You Invest $1,000 in TransMedics Group Right Now?

Before you consider TransMedics Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TransMedics Group wasn't on the list.

While TransMedics Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [TMDX.US - TransMedics](https://longbridge.com/en/quote/TMDX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| TransMedics 宣佈在馬薩諸塞州薩默維爾的 Assembly Innovation Park 建立新的全球總部並進行擴建 \| TMDX 股票新聞 | TransMedics Group, Inc. 宣佈與位於馬薩諸塞州薩默維爾的 Assembly Innovation Park 簽署了一項長期租約，以作為其新的全球總部，併購置了相鄰土地。這一擴展旨在提升公司的運營能力並吸引頂尖人才。馬薩 | [Link](https://longbridge.com/en/news/272275112.md) |
| 五年前投資 1000 美元於 TransMedics Group 的現值會是多少 | 投資 1000 美元於 TransMedics Group（NASDAQ:TMDX）五年前，現在的價值為 6750.92 美元，年化回報率為 46.51%。該公司的年均表現超出市場 33.44%，目前市值為 43.8 億美元。這突顯了複利對 | [Link](https://longbridge.com/en/news/270664120.md) |
| TransMedics Group Inc. 發佈了關於通過 OCS 平台革新器官移植的演示文稿 | TransMedics Group Inc. 發佈了一份關於其創新的器官護理系統（OCS）平台的演示文稿，該平台旨在解決傳統冷藏捐贈器官的侷限性。OCS 平台旨在通過持續的臨牀評估和集成生物傳感器來減少缺血損傷並增強器官的存活率。演示文稿強 | [Link](https://longbridge.com/en/news/272332645.md) |
| 市場對 TransMedics Group Inc 的看法如何？ | TransMedics Group Inc (NYSE:TMDX) 的空頭頭寸減少了 9.35%，目前有 700 萬股被賣空，佔可用股份的 35.11%。交易者平均需要 9.05 天來平倉他們的空頭頭寸。空頭頭寸的下降可能表明市場情緒更加樂 | [Link](https://longbridge.com/en/news/271347380.md) |
| TransMedics 簽署了新薩默維爾總部的租賃協議 | TransMedics Group Inc. 已與 BioMed Realty 簽署了一份租約，租賃位於馬薩諸塞州薩默維爾的 188 Assembly Park Drive 約 498,286 平方英尺的空間。該地點將成為公司新的總部，用於 | [Link](https://longbridge.com/en/news/272273886.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
